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Drug Addiction: Minireview
The Yin and Yang
of Hedonic Homeostasis
George F. Koob abused in humans increases the reward value of ICSS,
Department of Neuropharmacology and drug withdrawaldecreases the reward value of ICSS
The Scripps Research Institute (reviewed by Koob et al., 1993). The increases in reward
La Jolla, California 92037 threshold or decreases in reward have been observed
following the withdrawal of opiates, stimulants, and al-
Drug addiction is usually defined as compulsion to take cohol and appear to be dose related in that the more
a drug with loss of control over drug intake. The term drug that is administered over time, the larger the with-
substance dependence is used to describe a syndrome drawal response.
basically equivalent to addiction and the diagnostic cri- If a deficit reward state defines addiction, it could
teria used describe symptomsthat lead to loss of control be produced by several mechanisms. First, genetic or
in drug intake. Substance use, substance abuse, and environmental factors could produce some neurobio-
substance dependence are separate, definable entities logical deficit that requires reversal, perhaps by drug
in most formulations. An important challenge for neuro- initiation. Alternatively, chronic drug taking itself could
biological research is to understand how the transition produce a form of deficit state that required self-medica-
occurs between controlled drug use and the loss of tion to reverse. This type of deficit state could be hypoth-
control that defines addiction or substance dependence esized to exist at the molecular, cellular, and system
and what molecular, cellular, and system processes level, and theminireviews in this issuediscuss numerous
contribute to the development of drug dependence. A neuropharmacological mechanisms for such perturba-
neuroadaptive view of drug dependence was originally tions.
based on the phenomenon of tolerance and withdrawal, However, drug dependence not only involves acquisi-
adaptive processes that have been hypothesized to be tion of drug taking and maintenance of drug taking,
the body's attempt to counter the acute effects of the but also functions as a chronic relapsing disorder with
drug. Such adaptations have been explored at all levels reinstatement of drug taking after detoxification and ab-
of drug dependence research from the behavioral to the stinence. Both the positive and negative affective states
molecular (reviewed by Koob and Bloom, 1988). More can become associated with stimuli in the drug-taking
recently, another adaptive process, the phenomenon environment or even internal cues through classical con-
of sensitization, has been conceptualized as a critical ditioning processes (Wikler, 1973). Reexposure to these
neuroadaptive process (Robinson and Berridge, 1993). conditioned stimuli can provide the motivation for con-
tinued drug use and relapse after abstention. There is
Motivational View of Drug Dependence evidence in humans that the positive reinforcing effects
There are four major sources of reinforcement in drug of drugs such as heroin and cocaine, as measured by
dependence: positive reinforcement and negative rein- subjective reports of euphoria or ªhigh,º can become
forcement, conditioned positive reinforcement, and conditioned to previously neutral stimuli. Patients being
conditioned negative reinforcement (Wikler, 1973). treated for heroin addiction and allowed to self-adminis-
Clearly, positive reinforcing effects are critical for estab- ter either saline or heroin reported that both saline and
lishing self-administration behavior, which leads to the heroin injections were pleasurable, particularly in the
hypothesis that positive reinforcement is the key to drug patient's usual injection environment. Alternatively, pa-
dependence (Wise, 1988). In contrast, neuroadaptation tients, even detoxified subjects, can report negative af-
theories, such as opponent-process theory, postulate fective symptoms like those associated with drug absti-
that the processes of affective habituation (hedonic tol- nence when returning to environments similar to those
erance) and affective withdrawal may be the driving associated with drug dependence (O'Brien, 1976). The
force of addiction (Solomon, 1977). Clearly, this con- neurobiological bases for the syndrome of protracted
struct plays an important role in the maintenance of drug abstinence may involve subtle molecular and cellular
use after the development of dependence. Thus, while changes that are the challenge of future research on the
initial drug use may be motivated by the positive af- neurobiology of addiction. Key elements of some of the
fective state produced by the drug, continued use leads neuroadaptive processes that constitute protracted ab-
to neuroadaptation to the presence of drug and to an- stinence can be found in the minireviews of this issue.
other source of reinforcement, the negative reinforce-
ment associated with relieving negative affective conse-
Neuroadaptive Theories for Tolerancequences of drug termination. Indeed, the defining
and Withdrawalfeature of drug dependence has been argued to be the
Tolerance has been hypothesized to develop via twoestablishment of a negative affective state (Russell,
possible mechanisms. Habituation occurs when the pri-1976).
mary response to the drug diminishes with repeatedWhile a negative affective state is difficult to measure
presentation. Alternatively, the initial acute effect of thein animals, there is evidence of a compromised brain
drug may be opposed or counteracted by homeostaticreward system during drug withdrawal in chronically
changes in systems that mediate the primary drug ef-exposed animals. Intracranial self-stimulation (ICSS) be-
fects, i.e., a homeostatic adaptive process. These twohavior has proven to be particularly sensitive to changes
models are not necessarily mutually exclusive (Littletonin the brain reward systems during the course of drug
dependence. Acute administration of drugs that are and Little, 1989).
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In the opponent-process theory, both tolerance and Cellular and Molecular Adaptations Associated
with Brain Motivational Systemsdependence are inextricably linked (Solomon, 1977). Ac-
cording to this theory, affective states, pleasant or aver- Opiates
Chronic morphine treatment has long been associatedsive, are automatically opposed by centrally mediated
mechanisms that reduce the intensity of these affective with increases in adenylate cyclase activity, an action
opposite to that of acute administration (Nestler, 1996states. Thus, positive reinforcers such as drugs engage
positive hedonic processes that are opposed by nega- [this issue of Neuron]). These effects have not only been
observed in the locus coeruleus, a brain structure impli-tive hedonic processes. The positive hedonic processes
are hypothesized to be simple and stable and to follow cated in the physical signs of opiate withdrawal, but
also in the region of the nucleus accumbens, a structureadministration of the drug closely in time. In contrast,
the negative hedonic processes are of longer latency, implicated in the motivational effects of opiate with-
drawal. In addition, chronic opiate exposure also de-slow to build up strength, and slow to decay. Within this
framework, the intense pleasure of a drug ªrushº or creases levels of neurofilament protein in the ventral
tegmental area, which contains the cell bodies of originªhighº is presumed to reflect a positive hedonic process,
and the negative mood state associated with the drug of the dopamine (DA) projection to the nucleus accum-
bens; administration of neurotrophic factors can reversewearing off or abstinence following a drug binge is
presumed to reflect the opponent negative hedonic these effects. Injection of brain-derived neurotrophic
factor into the brain prevented and reversed the struc-process.
tural changes observed in the ventral tegmental area
DA neurons as well as the changes in cyclic AMP (cAMP)
Sensitization activity in the nucleus accumbens (Nestler, 1996). This
Sensitization has been defined as the long-lasting incre- opens the possibility that the long-term neuroadapt-
ment in response occurring upon repeated presentation ations associated with opiate dependence that have
of a stimulus that reliably elicits a response at its initial motivational consequences may involve changes in
presentation. With drugs, sensitization is more likely to mesolimbic DA function that can be regulated by neuro-
occur with intermittent exposure to a drug, in contrast trophic factors.
with tolerance, which is more likely to occur with contin- Cocaine and Amphetamine
uous exposure. In a recent conceptualization of the role Two major neurobiological actions of cocaine and am-
of sensitization in drug dependence, drug craving was phetamine may represent neuroadaptations important
hypothesized tobe progressively increased by repeated for motivational effects of these drugs. Activation of D1
exposure to drugs of abuse (Robinson and Berridge, receptors stimulates a cascade of events that ultimately
1993); the transition to pathologically strong craving lead to cAMP response element±binding protein (CREB)
would then define compulsive use. phosphorylation and subsequent alterations in gene ex-
pression (Hyman, 1996 [this issue of Neuron]). These
within-system adaptations not only could change the
Within-System and function of the DA system itself but may also trigger a
Between-System Neuroadaptations second major neurobiological action, the increase in
In an attempt tobring homeostatic models to the cellular expression of protachykinin and prodynorphin mRNA.
and molecular levels of analysis, adaptations can be The subsequent activation of dynorphin systems could
distinguished between those occurring within a drug- contribute to the dysphoric syndrome associated with
sensitive reinforcement system and those occurring be- cocaine dependence and also provide feedback to de-
tween interactingsystems (Koob and Bloom, 1988). Sim- crease DA release. Enhanced dynorphin actions could
ilar neurobiological distinctions could also be made for then be considered a between-system adaptation. The
the neuroadaptations associated with sensitization. In a significance of the D1 receptor±cAMP±CREB pathway
within-system adaptation, repeated drug administration in adaptations to drugs of abuse is supported by the
would elicit an opposing reaction within the same sys- recent evidence of effective anti-cocaine actions from
tem in which the drug elicits its primary reinforcing ac- DA D1 antagonists and effective anti-cocaine priming
tions. In a between-system adaptation, repeated drug effects of D1 agonists (Self et al., 1996).
administration would recruit a different neurochemical Nicotine
system, one not involved in the acute reinforcing effects The initial molecular site of action for nicotine is likely
of the drug but one that, when activated or engaged, to be the nicotinic acetylcholine receptors, specifically
would act inopposition to the primary reinforcing effects those localized in the brain mesolimbic DA system. The
of the drug. capability of these receptors to exist in many different
Many examples of within-system and between-sys- functional states has led to a combined within-system/
tem adaptations can be found in the four minireviews between-system adaptation hypothesis to explain toler-
to follow. Some of these neuroadaptations are specific ance and dependence (Dani and Heinemann, 1996 [this
to each drug class, while others may be common to all issue of Neuron]). Acute nicotine briefly stimulates re-
drugs of abuse. Even more intriguing is the possibility ceptors that are normally in a closed resting state to an
that the added system dimension of neurobiological cir- open state for conducting cations, but then they return
cuitry may represent not only a common substrate for to a desensitized state in which they are unresponsive
the reinforcing actions of drugs but a common substrate to the agonist. In addition, long-term nicotine exposure
for the neuroadaptations known as substance depen- causes an increase in the actual number of nicotinic
acetylcholine receptors. Thus, the following scenariodence or addiction.
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has been hypothesized by Dani and Heinemann. Nico- observation that opioid antagonist administration can
tine stimulates the mesolimbic DA system, among other help prevent relapse in detoxified alcoholics (Koob,
systems, via activation of nicotinic acetylcholine recep- 1996). Serotonin has been implicated in the acute rein-
tors to produce the reinforcing effects of nicotine. The forcing effects of ethanol by the observation that seroto-
inactivation of the receptors by desensitization leads to nin reuptake inhibitors decrease ethanol intake in ani-
acute tolerance, which is compensated by an increase mals and humans (Koob, 1996). All of these changes
in receptors. During abstinence, the smoker's nicotine would be considered within-system changes where the
levels fall, and the excess nicotinic acetylcholine recep- neurotransmitter system responsible for part of the
tors begin to recover to a responsive state. However, acute reinforcing actions of ethanol is altered by chronic
this heightened responsitivity to ordinary synaptic input exposure to ethanol.
in the acetylcholinergic pathways would not be re- One example of a potential between-system neuroa-
stricted to the receptors on the DA system but may daptation with chronic ethanol is the activation of the
engage nicotinic receptors on other, nonrewarding ace- neuropeptide corticotropin-releasing factor (CRF), a
tylcholinergic pathways that could contribute to the neg- peptide implicated in behavioral responses to stressors.
ative affectivestate associated with nicotine withdrawal. CRF antagonists injected into the amygdala reverse the
Smokers are, in effect, medicating themselveswith nico- anxiogenic-like effects of ethanol withdrawal, and etha-
tine to regulate the number of functional nicotinic acetyl- nol withdrawal is characterized by increased release of
choline receptors according to this hypothesis. CRF into the amygdala (Koob et al., 1994a; Pich et al.,
Alcohol
1995).
A major advance in recent years has been the discovery
of significant selectivity in the initial site of action of
ethanol, particularly for low doses. Rather than acting
Common Neuropharmacological Elements
through relatively unselective perturbations of mem-
in Addictionbrane lipids, ethanol appears to act selectively on pro-
The changes in the brain associated with the develop-teins involved in signal transmission and transduction
ment of drug dependence outlined above have several(Tabakoff and Hoffman, 1996 [this issue of Neuron]).
common elements that may define a basic drug ad-Five neurotransmitter systems have been implicated in
diction circuitry. This circuitry can be defined at threethe acute reinforcing actions of ethanol: g-aminobutyric
levels of inquiry: molecular, neurochemical, or neuroan-acid (GABA), glutamate, DA, serotonin, and opioid pep-
atomical.tides (Koob et al., 1994b). Recent work has begun to
Within-Systemidentify elements of neuroadaptation in these neuro-
A system common to the acute and chronic actions oftransmitter systems that result from chronic administra-
all drugs of abuse is the mesolimbic DA system. Activa-tion of ethanol. Pharmacological data suggest a role for
tion of this system is critical for the reinforcing actions ofGABA in ethanol dependence in that GABA agonists
stimulants, possibly including nicotine. The mesolimbicattenuate ethanol withdrawal and GABA antagonists ex-
DA system also participates in opiate and alcohol rein-acerbate ethanol withdrawal. At a molecular level, there
forcement, although its integrity is not critical to supportare data showing that the potentiation by ethanol of
GABA-stimulated chloride flux is greatly reduced by self-administration of those drugs. Drug withdrawal is
chronic exposure to ethanol, and there are changes accompanied by a decrease in DA function, and ele-
in the expression of particular subunits of the GABAA ments of protracted abstinence may involve long-term
receptor with chronic ethanol exposure. changes in the DA system. Neuroadaptation within this
In contrast with the potentiation of GABA signaling, system clearly can develop by various means from the
there is significant evidence that acute ethanol at quite desensitization of nicotinic receptors (Dani and Heine-
low doses decreases glutamate (NMDA) receptor func- mann, 1996) to the induction of signal transduction ele-
tion, possibly through an action on the glycine site of ments pre- and postsynaptically to changes in response
the receptor. Chronic treatment with ethanol appears to to growth factors (Nestler, 1996). Evidence is strong for
increase the number of binding sites for NMDA receptor changes in opiate receptor signal transduction associ-
ligands that again may reflect changes in the absolute ated with chronic opiates (Nestler, 1996), but indirect
or relative quantity of NMDA receptor subunit proteins.
evidence also exists for changes with cocaine and even
These effects on GABAA and NMDA receptor function chronic ethanol (Nestler, 1992).
may be examples of within-system adaptations, but the
Between-System
link to actual motivational effects of ethanol dependence
Evidence for between-systems adaptations followingremains to be determined.
chronic drugs of abuse can be found instudies exploringTwo brain systems definitely linked to the motivational
the role of several neuropeptides, notably dynorphin,effects of ethanol are the DA system and the opioid
CRF, and neuropeptide FF (NPFF). Dynorphin peptidespeptide systems. Ethanol does appear to activate the
appear to regulate the DA system via an action of kmesolimbic DA system, possibly through an interaction
opioid receptors on DA nerve terminals; and k agonistswith NMDA receptors, but perhaps more intriguing is
produce aversive effects in rodents and humans (Hy-the observation that DA function is decreased during
man, 1996). Thus, the induction of prodynorphin geneethanol withdrawal, and this decrease is reversed by
by chronic administration of cocaine or amphetamineethanol administration (Koob, 1996). A role for opioid
could be an example of a neuroadaptation that is re-peptides in ethanol dependence derives from the pre-
cruited by the chronic drug exposure but has opposingclinical observation of a decrease in ethanol self-admin-
istration with opioid antagonists and from the clinical effects on brain reinforcement systems.
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Immunoreactivity for NPFF and its receptors has been to stimuli that predict drug effects or both. One could
reported in the CNS of the rat. Anti-opiate activities of speculate that the combination would be particularly
NPFF have been hypothesized based on the effects of powerful as a motivator for reinstatement of drug use.
intracerebroventricular (ICV) injection of NPFF-related Animal models of drug craving and relapse are being
peptides (Malin et al., 1990). NPFF attenuates morphine- developed and refined and usually reflect secondary
and stress-induced analgesia, and an NPFF antago- sources of reinforcement. The neural substrates for con-
nist can increase both morphine- and stress-induced ditioned positive reinforcement may involve elements
analgesia and reverse morphine tolerance. ICV adminis- of afferent input of the extended amygdala such as the
tration of an NPFF antagonist also attenuates a nalox- afferents from the basolateral amygdala and the meso-
one-precipitated withdrawal syndrome in morphine-de- limbic DA system. The neural substrates for conditioned
pendent rats. It remains to be determined whether these negative reinforcement are largely unknown. The chal-
anti-opiate peptides have motivational significance and lenge for future studies in the neurobiology of drug
contribute to the negative affective state produced dur- dependence will be to elucidate the neuroadaptive
ing drug abstinence. changes, such as changes in signal transduction func-
CRF is another neuropeptide that may be involved tion and gene expression, produced by chronic drug use
in the motivational aspects of drug dependence. Rats in animal models of protracted abstinence and relapse.
treatedrepeatedly with cocaine and ethanol showsignif- Presumably, the same molecular and cellular changes
icant anxiogenic-like responses following cessation of in the neurochemical systems and neurocircuitry re-
chronic drug administration that are reversed with ICV sponsible for the positive and negative reinforcement
administration of a CRF antagonist (Koob et al., 1994a). associated with chronic drug use will hold the key.
However, a CRF antagonist was also active in reversing
the aversive effects of opiate withdrawal (Heinrichs et Selected Reading
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